{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,16]],"date-time":"2026-06-16T01:23:05Z","timestamp":1781572985981,"version":"3.54.5"},"reference-count":22,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2025,5,1]]},"DOI":"10.7759\/cureus.83285","type":"journal-article","created":{"date-parts":[[2025,5,1]],"date-time":"2025-05-01T08:34:43Z","timestamp":1746088483000},"source":"Crossref","is-referenced-by-count":2,"title":["Placental Growth Factor as a Predictor of Adverse Maternal Outcomes in Patients With Hypertensive Disorders of Pregnancy: A Prospective Observational Study"],"prefix":"10.7759","author":[{"given":"Rakshitha","family":"Raghavendra","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shailaja","family":"Bidri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rajasri G","family":"Yaliwal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Neelamma","family":"Patil","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aruna","family":"Biradar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Preeti S","family":"Malapure","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1186\/s12872-015-0110-5","article-title":"Prevalence of pregnancy induced hypertension and pregnancy outcomes among women seeking maternity services in Harare, Zimbabwe","volume":"15","author":"Muti M","year":"2015","unstructured":"Muti M, Tshimanga M, Notion GT, Bangure D, Chonzi P. Prevalence of pregnancy induced hypertension and pregnancy outcomes among women seeking maternity services in Harare, Zimbabwe. BMC Cardiovasc Disord. 2015, 15:111. 10.1186\/s12872-015-0110-5","journal-title":"BMC Cardiovasc Disord"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1016\/j.ccl.2020.09.005","article-title":"Hypertensive disorders of pregnancy","volume":"39","author":"Khedagi AM","year":"2021","unstructured":"Khedagi AM, Bello NA. Hypertensive disorders of pregnancy. Cardiol Clin. 2021, 39:77-90. 10.1016\/j.ccl.2020.09.005","journal-title":"Cardiol Clin"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1111\/1471-0528.16425","article-title":"Placental growth factor in suspected preterm pre-eclampsia: a review of the evidence and practicalities of implementation","volume":"127","author":"Hurrell A","year":"2020","unstructured":"Hurrell A, Beardmore-Gray A, Duhig K, Webster L, Chappell LC, Shennan AH. Placental growth factor in suspected preterm pre-eclampsia: a review of the evidence and practicalities of implementation. BJOG. 2020, 127:1590-7. 10.1111\/1471-0528.16425","journal-title":"BJOG"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1016\/j.ajog.2020.10.022","article-title":"Imbalances in circulating angiogenic factors in the pathophysiology of preeclampsia and related disorders","volume":"226","author":"Rana S","year":"2022","unstructured":"Rana S, Burke SD, Karumanchi SA. Imbalances in circulating angiogenic factors in the pathophysiology of preeclampsia and related disorders. Am J Obstet Gynecol. 2022, 226:S1019-34. 10.1016\/j.ajog.2020.10.022","journal-title":"Am J Obstet Gynecol"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1097\/GRF.0000000000000267","article-title":"Angiogenic and antiangiogenic markers for prediction and risk classification of preeclampsia","volume":"60","author":"Malshe AK","year":"2017","unstructured":"Malshe AK, Sibai BM. Angiogenic and antiangiogenic markers for prediction and risk classification of preeclampsia. Clin Obstet Gynecol. 2017, 60:134-40. 10.1097\/GRF.0000000000000267","journal-title":"Clin Obstet Gynecol"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa031884","article-title":"Circulating angiogenic factors and the risk of preeclampsia","volume":"350","author":"Levine RJ","year":"2004","unstructured":"Levine RJ, Maynard SE, Qian C, et al.. Circulating angiogenic factors and the risk of preeclampsia. N Engl J Med. 2004, 350:672-83. 10.1056\/NEJMoa031884","journal-title":"N Engl J Med"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1080\/14767050400028816","article-title":"Plasma soluble vascular endothelial growth factor receptor-1 concentration is elevated prior to the clinical diagnosis of pre-eclampsia","volume":"17","author":"Chaiworapongsa T","year":"2005","unstructured":"Chaiworapongsa T, Romero R, Kim YM, et al.. Plasma soluble vascular endothelial growth factor receptor-1 concentration is elevated prior to the clinical diagnosis of pre-eclampsia. J Matern Fetal Neonatal Med. 2005, 17:3-18. 10.1080\/14767050400028816","journal-title":"J Matern Fetal Neonatal Med"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1097\/AOG.0000000000003694","article-title":"Placental growth factor and the risk of adverse neonatal and maternal outcomes","volume":"135","author":"Parchem JG","year":"2020","unstructured":"Parchem JG, Brock CO, Chen HY, Kalluri R, Barton JR, Sibai BM. Placental growth factor and the risk of adverse neonatal and maternal outcomes. Obstet Gynecol. 2020, 135:665-73. 10.1097\/AOG.0000000000003694","journal-title":"Obstet Gynecol"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1016\/j.preghy.2020.10.005","article-title":"Placental growth factor measurements in the assessment of women with suspected preeclampsia: a stratified analysis of the PARROT trial","volume":"23","author":"Duhig KE","year":"2021","unstructured":"Duhig KE, Myers JE, Gale C, et al.. Placental growth factor measurements in the assessment of women with suspected preeclampsia: a stratified analysis of the PARROT trial. Pregnancy Hypertens. 2021, 23:41-7. 10.1016\/j.preghy.2020.10.005","journal-title":"Pregnancy Hypertens"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1001\/jamanetworkopen.2024.44454","article-title":"Midpregnancy placental growth factor screening and early preterm birth","volume":"7","author":"Gladstone RA","year":"2024","unstructured":"Gladstone RA, Ahmed S, Huszti E, et al.. Midpregnancy placental growth factor screening and early preterm birth. JAMA Netw Open. 2024, 7:e2444454. 10.1001\/jamanetworkopen.2024.44454","journal-title":"JAMA Netw Open"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1161\/HYPERTENSIONAHA.121.17047","article-title":"PLGF (placental growth factor) testing in clinical practice: evidence from a Canadian tertiary maternity referral center","volume":"77","author":"McLaughlin K","year":"2021","unstructured":"McLaughlin K, Snelgrove JW, Audette MC, et al.. PLGF (placental growth factor) testing in clinical practice: evidence from a Canadian tertiary maternity referral center. Hypertension. 2021, 77:2057-65. 10.1161\/HYPERTENSIONAHA.121.17047","journal-title":"Hypertension"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1161\/HYPERTENSIONAHA.120.15552","article-title":"Usefulness of the sFlt-1\/PlGF (soluble fms-like tyrosine kinase-1\/placental growth factor) ratio in diagnosis or misdiagnosis in women with clinical diagnosis of preeclampsia","volume":"76","author":"Lea\u00f1os-Miranda A","year":"2020","unstructured":"Lea\u00f1os-Miranda A, Graciela Nolasco-Lea\u00f1os A, Ismael Carrillo-Ju\u00e1rez R, et al.. Usefulness of the sFlt-1\/PlGF (soluble fms-like tyrosine kinase-1\/placental growth factor) ratio in diagnosis or misdiagnosis in women with clinical diagnosis of preeclampsia. Hypertension. 2020, 76:892-900. 10.1161\/HYPERTENSIONAHA.120.15552","journal-title":"Hypertension"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2393-13-161","article-title":"Comparison of placental growth factor and fetal flow Doppler ultrasonography to identify fetal adverse outcomes in women with hypertensive disorders of pregnancy: an observational study","volume":"13","author":"Molvarec A","year":"2013","unstructured":"Molvarec A, Gullai N, Stenczer B, F\u00fcgedi G, Nagy B, Rig\u00f3 J Jr. Comparison of placental growth factor and fetal flow Doppler ultrasonography to identify fetal adverse outcomes in women with hypertensive disorders of pregnancy: an observational study. BMC Pregnancy Childbirth. 2013, 13:161. 10.1186\/1471-2393-13-161","journal-title":"BMC Pregnancy Childbirth"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1002\/uog.3930","article-title":"Angiogenic growth factor levels in maternal and fetal blood: correlation with Doppler ultrasound parameters in pregnancies complicated by pre-eclampsia and intrauterine growth restriction","volume":"29","author":"Schlembach D","year":"2007","unstructured":"Schlembach D, Wallner W, Sengenberger R, Stiegler E, M\u00f6rtl M, Beckmann MW, Lang U. Angiogenic growth factor levels in maternal and fetal blood: correlation with Doppler ultrasound parameters in pregnancies complicated by pre-eclampsia and intrauterine growth restriction. Ultrasound Obstet Gynecol. 2007, 29:407-13. 10.1002\/uog.3930","journal-title":"Ultrasound Obstet Gynecol"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1161\/HYPERTENSIONAHA.118.12205","article-title":"Angiogenic factor estimation as a warning sign of preeclampsia-related peripartum morbidity among hospitalized patients","volume":"73","author":"Lopes Perdigao J","year":"2019","unstructured":"Lopes Perdigao J, Chinthala S, Mueller A, et al.. Angiogenic factor estimation as a warning sign of preeclampsia-related peripartum morbidity among hospitalized patients. Hypertension. 2019, 73:868-77. 10.1161\/HYPERTENSIONAHA.118.12205","journal-title":"Hypertension"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.1161\/HYPERTENSIONAHA.117.10803","article-title":"Hypertensive disorders of pregnancy: ISSHP classification, diagnosis, and management recommendations for international practice","volume":"72","author":"Brown MA","year":"2018","unstructured":"Brown MA, Magee LA, Kenny LC, et al.. Hypertensive disorders of pregnancy: ISSHP classification, diagnosis, and management recommendations for international practice. Hypertension. 2018, 72:24-43. 10.1161\/HYPERTENSIONAHA.117.10803","journal-title":"Hypertension"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.1016\/j.placenta.2016.03.010","article-title":"Placental growth factor as a marker of fetal growth restriction caused by placental dysfunction","volume":"42","author":"Benton SJ","year":"2016","unstructured":"Benton SJ, McCowan LM, Heazell AE, et al.. Placental growth factor as a marker of fetal growth restriction caused by placental dysfunction. Placenta. 2016, 42:1-8. 10.1016\/j.placenta.2016.03.010","journal-title":"Placenta"},{"key":"ref18","article-title":"The role of placental growth factor in predicting preeclampsia: diagnostic accuracy and clinical applications","volume":"30","author":"Das DB","year":"2025","unstructured":"Das DB, Patra KK, Samanta AP. The role of placental growth factor in predicting preeclampsia: diagnostic accuracy and clinical applications. Dialogues Cardiovasc Med. 2025, 30:49-56.","journal-title":"Dialogues Cardiovasc Med"},{"key":"ref19","article-title":"Placental growth factor (PLGF)-based biomarker testing to help diagnose pre-eclampsia in people with suspected pre-eclampsia: a health technology assessment","volume":"23","author":"Ontario Health (Quality)","year":"2023","unstructured":"Ontario Health (Quality). Placental growth factor (PLGF)-based biomarker testing to help diagnose pre-eclampsia in people with suspected pre-eclampsia: a health technology assessment. Ont Health Technol Assess Ser. 2023, 23:1-146.","journal-title":"Ont Health Technol Assess Ser"},{"key":"ref20","doi-asserted-by":"publisher","DOI":"10.4236\/ojog.2021.116070","article-title":"Placenta growth factor and soluble Fms-like tyrosine kinase 1 in preeclampsia and normotensive pregnant Nigerian women","volume":"11","author":"Gbadegesin A","year":"2021","unstructured":"Gbadegesin A, Agbara JO, Rabiu KA, et al.. Placenta growth factor and soluble Fms-like tyrosine kinase 1 in preeclampsia and normotensive pregnant Nigerian women. Open J Obstet Gynecol. 2021, 11:753-62. 10.4236\/ojog.2021.116070","journal-title":"Open J Obstet Gynecol"},{"key":"ref21","doi-asserted-by":"publisher","DOI":"10.1016\/j.xagr.2023.100177","article-title":"Correlation of sFlt\/PlGF ratio with severity of preeclampsia in an Indian population","volume":"3","author":"Kumar N","year":"2023","unstructured":"Kumar N, Das V, Agarwal A, Agrawal S. Correlation of sFlt\/PlGF ratio with severity of preeclampsia in an Indian population. AJOG Glob Rep. 2023, 3:100177. 10.1016\/j.xagr.2023.100177","journal-title":"AJOG Glob Rep"},{"key":"ref22","doi-asserted-by":"publisher","DOI":"10.3389\/fsurg.2022.1005974","article-title":"Dynamic risk prediction models for different subtypes of hypertensive disorders in pregnancy","volume":"9","author":"Zhang X","year":"2022","unstructured":"Zhang X, Xu Q, Yang L, et al.. Dynamic risk prediction models for different subtypes of hypertensive disorders in pregnancy. Front Surg. 2022, 9:1005974. 10.3389\/fsurg.2022.1005974","journal-title":"Front Surg"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/363816-placental-growth-factor-as-a-predictor-of-adverse-maternal-outcomes-in-patients-with-hypertensive-disorders-of-pregnancy-a-prospective-observational-study","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,1]],"date-time":"2025-05-01T08:34:44Z","timestamp":1746088484000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/363816-placental-growth-factor-as-a-predictor-of-adverse-maternal-outcomes-in-patients-with-hypertensive-disorders-of-pregnancy-a-prospective-observational-study"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,5,1]]},"references-count":22,"URL":"https:\/\/doi.org\/10.7759\/cureus.83285","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2025,5,1]]}}}